Genomics BioSci & Tech. Statistics
Total Valuation
TPEX:4195 has a market cap or net worth of TWD 1.79 billion. The enterprise value is 2.28 billion.
| Market Cap | 1.79B |
| Enterprise Value | 2.28B |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4195 has 72.45 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 72.45M |
| Shares Outstanding | 72.45M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.96% |
| Owned by Institutions (%) | 4.58% |
| Float | 52.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.18 |
| PB Ratio | 2.98 |
| P/TBV Ratio | 3.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.79 |
| EV / Sales | 4.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.79 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.35 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.28 |
| Interest Coverage | -10.36 |
Financial Efficiency
Return on equity (ROE) is -28.95% and return on invested capital (ROIC) is -6.05%.
| Return on Equity (ROE) | -28.95% |
| Return on Assets (ROA) | -5.46% |
| Return on Invested Capital (ROIC) | -6.05% |
| Return on Capital Employed (ROCE) | -12.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.51% in the last 52 weeks. The beta is 0.04, so TPEX:4195's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +33.51% |
| 50-Day Moving Average | 25.10 |
| 200-Day Moving Average | 21.37 |
| Relative Strength Index (RSI) | 51.62 |
| Average Volume (20 Days) | 92,260 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4195 had revenue of TWD 563.09 million and -178.49 million in losses. Loss per share was -2.46.
| Revenue | 563.09M |
| Gross Profit | 163.10M |
| Operating Income | -115.33M |
| Pretax Income | -202.74M |
| Net Income | -178.49M |
| EBITDA | -57.70M |
| EBIT | -115.33M |
| Loss Per Share | -2.46 |
Balance Sheet
The company has 177.23 million in cash and 592.47 million in debt, giving a net cash position of -415.24 million or -5.73 per share.
| Cash & Cash Equivalents | 177.23M |
| Total Debt | 592.47M |
| Net Cash | -415.24M |
| Net Cash Per Share | -5.73 |
| Equity (Book Value) | 601.23M |
| Book Value Per Share | 7.23 |
| Working Capital | 151.17M |
Cash Flow
In the last 12 months, operating cash flow was -140.25 million and capital expenditures -119.30 million, giving a free cash flow of -259.54 million.
| Operating Cash Flow | -140.25M |
| Capital Expenditures | -119.30M |
| Free Cash Flow | -259.54M |
| FCF Per Share | -3.58 |
Margins
Gross margin is 28.96%, with operating and profit margins of -20.48% and -31.70%.
| Gross Margin | 28.96% |
| Operating Margin | -20.48% |
| Pretax Margin | -36.01% |
| Profit Margin | -31.70% |
| EBITDA Margin | -10.25% |
| EBIT Margin | -20.48% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:4195 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | -9.97% |
| FCF Yield | -14.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 8, 2023. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 8, 2023 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
TPEX:4195 has an Altman Z-Score of 1.13 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.13 |
| Piotroski F-Score | 4 |